Drug shortage: Hydromorphone Hydrochloride Injection (HYDROMORPHONE HYDROCHLORIDE, DILAUDID)
FDA lists 26 presentations as Current. Availability: Unavailable (7), Limited Availability (3), Available (16). Reason: Other; Demand increase for the drug. Companies: Fresenius Kabi USA, LLC, Hospira, Inc., a Pfizer Company, Teva Pharmaceuticals USA, Inc., Hikma Pharmaceuticals USA, Inc..
- Published by source
- 2017-10-31
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Fresenius Kabi USA, LLC
- Products
- Hydromorphone Hydrochloride Injection HYDROMORPHONE HYDROCHLORIDE DILAUDID
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- Next release October 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2017-10-31
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #901 | new | 2026-10-22 | d4422fbb2813…70f8a9 | 6c4b1d2686b5…917576 |
Chain head: #1076 8ad5adc30b9b…88ce20